Bisphosphonate-related osteonecrosis of the jaw in four Nordic countries and an indication of under-reporting

References

• Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1999;348:1535–41.
   Google Scholar
• Otto S, Schreyer C, Hafner S, Mast G, Ehrenfeld M, Stürzenbaum S, et al. Bisphosphonate-related osteonecrosis of the jaws - Characteristics, risk factors, clinical features, localization and impact on oncological treatment. J Craniomaxillofac Surg 2012;40:303–9.
   PubMed Web of Science ®Google Scholar
• Advisory Task Force on Bisphosphonate. Related Osteonecrosis of the Jaws. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofacial Surg 2007;65:369–76.
   PubMed Web of Science ®Google Scholar
• Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61:1115–17.
   PubMed Web of Science ®Google Scholar
• Wang J, Goodger NM, Pogrel MA. Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 2003;61:1104–7.
   PubMed Web of Science ®Google Scholar
• Migliorati CA. Bisphosphanates and oral cavity avascular bone necrosis. J Clin Oncol 2003;21:4253–4.
   PubMed Web of Science ®Google Scholar
• Thirstrup S. CHMP assessment report on bisphosphonates and osteonecrosis of the jaw. The European Medicines Agency; 2010. Available online at www.ema.europa.eu/docs/en_GB/document_library/Report/2010/01/WC500051428.pdf. Accessed 10 April 2012.
   Google Scholar
• Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B; Task Force on bisphosphonate-related osteonecrosis of the jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update. Aust Endod J 2009;35:119–30.
   PubMed Web of Science ®Google Scholar
• Lo JC, O'Ryan FS, Gordon NP, Yang J, Hui RL, Martin D, et al. Predicting Risk of Osteonecrosis of the Jaw with Oral Bisphosphonate Exposure (PROBE) Investigators. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg 2010;68:243–53.
   PubMed Web of Science ®Google Scholar
• World Health Organization. The importance of pharmacovigilance: safety monitoring of medicinal products. Geneva: WHO, 2002. online Available online at http://apps.who.int/medicinedocs/en/d/Js4893e/. accessed 2 April 2012.
   Google Scholar
• Directive 2010/84/EU of the European Parliament and of the Council of 15 December 2010. Available online at http://ec.europa.eu/health/files/eudralex/vol–1/dir_2010_84/dir_2010_84_en.pdf. Accessed 20 March 2012.
   Google Scholar
• Vollset SE. Confidence intervals for a binomial proportion. Stat Med 1993;12:809–24; Erratum in: Stat Med 1995;14:875.
   PubMed Web of Science ®Google Scholar
• The Uppsala Monitoring Centre. Pharmacovigilance, The WHO programme; 2012. Available online at http://www.who-umc.org/. Accessed 2 April 2012.
   Google Scholar
• González-Rubio F, Calderón-Larrañaga A, Poblador-Plou B, Navarro-Pemán C, López-Cabañas A, Prados-Torres A. Underreporting of recognized adverse drug reactions by primary care physicians: an exploratory study. Pharmacoepidemiol Drug Saf 2011;20:1287–94.
   PubMed Web of Science ®Google Scholar
• Cox AR, Anton C, McDowell SE, Marriott JF, Ferner RE. Correlates of spontaneous reporting of adverse drug reactions within primary care: the paradox of low prescribers who are high reporters. Br J Clin Pharmacol 2010;69:529–34.
   PubMed Web of Science ®Google Scholar
• Sharikabad M. Bisfosfonatrelatert kjevebensnekrose; europeiske og norske erfaringer. Norsk Farmaceutisk Tidsskr 2012;1:26–9.
   Google Scholar
• Heeley E, Riley J, Layton D, Wilton LV, Shakir SA. Prescription-event monitoring and reporting of adverse drug reactions. Lancet 2011;358:1872–3.
   Google Scholar
• Werner CA. U.S. Census Bureau brief on data from the 2010 Census. 2010. Available online at http://www.census.gov/prod/cen2010/briefs/c2010br-09.pdf. Accessed 7 March 2012.
   Google Scholar
• Schnatz PF. The 2010 North American Menopause Society position statement: updates on screening, prevention and management of postmenopausal osteoporosis. Conn Med 2011;75:485–7.
   PubMedGoogle Scholar